Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling. (Q37642136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

review article

1 reference

title

Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

arteriosclerotic heart disease

13 February 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Constantinos Pantos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Dennis V Cokkinos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

29 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

157-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

In vivo gene delivery of HSP70i by adenovirus and adeno-associated virus preserves contractile function in mouse heart following ischemia-reperfusion

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Triiodo-L-thyronine rapidly stimulates alveolar fluid clearance in normal and hyperoxia-injured lungs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Postischemic recovery of mechanical performance and energy metabolism in the presence of left ventricular hypertrophy. A 31P-MRS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

A review of studies relating to thyroid hormone therapy in brain-dead organ donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Effects of triiodothyronine supplementation after myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Triiodothyronine-enhanced left ventricular function after ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

AlphaB crystallin translocation and phosphorylation: signal transduction pathways and preconditioning in the isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Acute severe postischemic myocardial depression reversed by triiodothyronine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Effect of triiodothyronine on postischemic myocardial function in the isolated heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Nuclear localization of protein kinase C-alpha induces thyroid hormone receptor-alpha1 expression in the cardiomyocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone and cardiac contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone-targeting the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

DITPA prevents the blunted contraction-frequency relationship in myocytes from infarcted hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Morphine administration at reperfusion fails to improve postischaemic cardiac function but limits myocardial injury probably via heat-shock protein 27 phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Long-term thyroxine administration increases heat stress protein-70 mRNA expression and attenuates p38 MAP kinase activity in response to ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Triiodothyronine levels for risk stratification of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

3,5,3′ triiodo-l-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

The expression of mRNA of cytokines and of extracellular matrix proteins in triiodothyronine-treated rat hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.11.006

10.1016/J.VPH.2009.11.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19951746%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference